Interleukin-17-mediated control of parasitemia in experimental Trypanosoma congolense infection in mice

Infection and Immunity

Volumn 78, Issue 12, 2010, Pages 5271-5279

  Mou, Zhirong ^a   Jia, Ping ^a   Kuriakose, Shiby ^a   Khadem, Forough ^a   Uzonna, Jude E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 6; NITRIC OXIDE; RECOMBINANT INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOPATHOGENESIS; INFECTION CONTROL; INFECTION SENSITIVITY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH17 CELL; TRYPANOSOMA CONGOLENSE;

ANIMALS; ANTIBODIES, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNITY, INNATE; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PARASITEMIA; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 78649924183     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00168-10     Document Type: Article

References (48)

1. Abe, T., T. Arai, A. Ogawa, T. Hiromatsu, A. Masuda, T. Matsuguchi, Y. Nimura, and Y. Yoshikai. 2004. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 40:414-423. (Pubitemid 39062859)
2. Aujla, S. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, S. Husain, J. L. Kreindler, P. J. Dubin, J. M. Pilewski, M. M. Myerburg, C. A. Mason, Y. Iwakura, and J. K. Kolls. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-281.
3. Bettelli, E., T. Korn, M. Oukka, and V. K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453:1051-1057.
4. Chauhan, S. K., J. El Annan, T. Ecoiffier, S. Goyal, Q. Zhang, D. R. Saban, and R. Dana. 2009. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J. Immunol. 182:1247-1252.
5. Du, C., C. Liu, J. Kang, G. Zhao, Z. Ye, S. Huang, Z. Li, Z. Wu, and G. Pei. 2009. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 10:1252-1259.
6. Ely, L. K., S. Fischer, and K. C. Garcia. 2009. Structural basis of receptor sharing by interleukin 17 cytokines. Nat. Immunol. 10:1245-1251.
7. Guilliams, M., G. Oldenhove, W. Noel, M. Herin, L. Brys, P. Loi, V. Flamand, M. Moser, P. De Baetselier, and A. Beschin. 2007. African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J. Immunol. 179:2748-2757.
8. He, R., M. K. Oyoshi, H. Jin, and R. S. Geha. 2007. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc. Natl. Acad. Sci. U. S. A. 104:15817-15822.
9. Huang, W., L. Na, P. L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
10. Iwakura, Y., S. Nakae, S. Saijo, and H. Ishigame. 2008. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226:57-79.
11. Kaushik, R. S., J. E. Uzonna, J. R. Gordon, and H. Tabel. 1999. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57BL/6 mice. Exp. Parasitol. 92:131-143.
12. Kaushik, R. S., J. E. Uzonna, Y. Zhang, J. R. Gordon, and H. Tabel. 2000. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-α, IL-6, IL-10, and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice. Cytokine 12:1024-1034.
13. Kelchtermans, H., E. Schurgers, L. Geboes, T. Mitera, J. Van Damme, J. Van Snick, C. Uyttenhove, and P. Matthys. 2009. Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res. Ther. 11:R122.
14. + T-cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377.
15. Kimura, A., T. Naka, and T. Kishimoto. 2007. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc. Natl. Acad. Sci. U. S. A. 104:12099-12104.
16. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27:485-517.
17. Kristjanson, P. M., B. M. Swallow, G. J. Rowlands, R. L. Kruska, and P. N. de Leeuw. 1999. Measuring the costs of African animal trypanosomosis, the potential benefits of control and returns to research. Agric. Syst. 59:79-98.
18. Krstic, A., V. Ilic, S. Mojsilovic, G. Jovcic, P. Milenkovic, and D. Bugarski. 2009. p38 MAPK signaling mediates IL-17-induced nitric oxide synthase expression in bone marrow cells. Growth Factors 27:79-90.
19. Lanham, S. M., and D. G. Godfrey. 1970. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp. Parasitol. 28:521-534.
20. Lee, Y. K., H. Turner, C. L. Maynard, J. R. Oliver, D. Chen, C. O. Elson, and C. T. Weaver. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity 30:92-107.
21. Mabbott, N. A., I. A. Sutherland, and J. M. Sternberg. 1995. Suppressor macrophages in Trypanosoma brucei infection: nitric oxide is related to both suppressive activity and life span in vivo. Parasite Immunol. 17:143-150.
22. Magez, S., M. Radwanska, M. Drennan, L. Fick, T. N. Baral, N. Allie, M. Jacobs, S. Nedospasov, F. Brombacher, B. Ryffel, and P. De Baetselier. 2007. Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing. J. Infect. Dis. 196:954-962.
23. Magez, S., M. Radwanska, M. Drennan, L. Fick, T. N. Baral, F. Brombacher, and P. De Baetselier. 2006. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 infections. J. Infect. Dis. 193:1575-1583.
24. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231-234.
25. Miljkovic, D., I. Cvetkovic, M. Momcilovic, D. Maksimovic-Ivanic, S. Stosic-Grujicic, and V. Trajkovic. 2005. Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. Cell Mol. Life Sci. 62:2658-2668.
26. Miljkovic, D., I. Cvetkovic, O. Vuckovic, S. Stosic-Grujicic, M. Mostarica Stojkovic, and V. Trajkovic. 2003. The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells. Cell Mol. Life Sci. 60:518-525.
27. Miljkovic, D., and V. Trajkovic. 2004. Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev. 15:21-32. (Pubitemid 38121288)
28. Murray, M., W. I. Morrison, and D. D. Whitelaw. 1982. Host susceptibility to African trypanosomiasis: trypanotolerance. Adv. Parasitol. 21:1-68.
29. Naylor, D. C. 1971. The hematology and histopathology of Trypanosoma congolense infection in cattle. I. Introduction and histopathology. Trop. Anim. Health Prod. 3:95-100.
30. O'Connor, W., Jr., M. Kamanaka, C. J. Booth, T. Town, S. Nakae, Y. Iwakura, J. K. Kolls, and R. A. Flavell. 2009. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10:603-609.
31. Ogawa, A., A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama. 2004. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110:55-62.
32. Okwor, I., H. Muleme, P. Jia, and J. E. Uzonna. 2009. Altered proinflammatory cytokine production and enhanced resistance to Trypanosoma congolense infection in lymphotoxin beta-deficient mice. J. Infect. Dis. 200:361-369.
33. Ouyang, W., J. K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:454-467. (Pubitemid 351471762)
34. Rudner, X. L., K. I. Happel, E. A. Young, and J. E. Shellito. 2007. Interleukin- 23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75:3055-3061.
35. Shi, M., W. Pan, and H. Tabel. 2003. Experimental African trypanosomiasis: IFN-γ mediates early mortality. Eur. J. Immunol. 33:108-118.
36. + T cells mediates early mortality in highly susceptible mice. J. Immunol. 176:1724-1732.
37. Shi, M. Q., C. R. Wang, G. J. Wei, W. L. Pan, G. Appleyard, and H. Tabel. 2006. Experimental African trypanosomiasis: lack of effective CD1d-restricted antigen presentation. Parasite Immunol. 28:643-647.
38. Shi, M. Q., G. J. Wei, and H. Tabel. 2007. Trypanosoma congolense infections: MHC class II-restricted immune responses mediate either protection or disease, depending on IL-10 function. Parasite Immunol. 29:107-111.
39. Stijlemans, B., M. Guilliams, G. Raes, A. Beschin, S. Magez, and P. De Baetselier. 2007. African trypanosomiasis: from immune escape and immunopathology to immune intervention. Vet. Parasitol. 148:3-13.
40. Tabel, H., G. Wei, and M. Shi. 2008. T cells and immunopathogenesis of experimental African trypanosomiasis. Immunol. Rev. 225:128-139.
41. Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker, and J. Peschon. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177:36-39. (Pubitemid 43939112)
42. Uzonna, J. E., R. S. Kaushik, J. R. Gordon, and H. Tabel. 1999. Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance. Parasite Immunol. 21:57-71.
43. Uzonna, J. E., R. S. Kaushik, J. R. Gordon, and H. Tabel. 1998. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-γ antibodies alters trypanosome-susceptible mice to a resistant-like phenotype. J. Immunol. 161:5507-5515.
44. Uzonna, J. E., R. S. Kaushik, J. R. Gordon, and H. Tabel. 1998. Immunoregulation in experimental murine Trypanosoma congolense infection: anti-IL-10 antibodies reverse trypanosome-mediated suppression of lymphocyte proliferation in vitro and moderately prolong the life span of genetically susceptible BALB/c mice. Parasite Immunol. 20:293-302.
45. - cells in the production of IL-4, IL-10, and IFN-gamma and in trypanosome-elicited immunosuppression. J. Immunol. 161:6189-6197.
46. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189. (Pubitemid 43214587)
47. Vincendeau, P., S. Daulouede, B. Veyret, M. L. Darde, B. Bouteille, and J. L. Lemesre. 1992. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp. Parasitol. 75:353-360.
48. Wei, G., and H. Tabel. 2008. Regulatory T cells prevent control of experimental African trypanosomiasis. J. Immunol. 180:2514-2521.